Chen XY - Search Results

1

Detection of Complement C1q B Chain Overexpression and Its Latent Molecular Mechanisms in Cervical Cancer Tissues Using Multiple Methods.

Lin ST, Liang ZQ, Chen XY, Ye XQ, Pang YY, Luo JY, Chen JH, Dang YW, Chen G. Lin ST, et al. Among authors: chen xy, chen jh, chen g. Int J Genomics. 2022 Oct 20;2022:8775330. doi: 10.1155/2022/8775330. eCollection 2022. Int J Genomics. 2022. PMID: 36313902 Free PMC article.

2

Clinicopathologic changes and molecular finding of epithelioid pleomorphic xanthoastrocytoma: a case report.

Luo W, Li C, Huang J, Chen X, Ma Y, Zeng L. Luo W, et al. Int J Clin Exp Pathol. 2018 Oct 1;11(10):5144-5148. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31949594 Free PMC article.

3

Diagnostic roles of proliferative markers in pathological Grade of T1 Urothelial Bladder Cancer.

Yang J, Li C, Tang Y, Guo F, Chen Y, Luo W, Chen X, Ma Y, Zeng L. Yang J, et al. J Cancer. 2021 Mar 5;12(9):2498-2506. doi: 10.7150/jca.52336. eCollection 2021. J Cancer. 2021. PMID: 33854611 Free PMC article.

4

Systematic analysis competing endogenous RNA coexpression network as a potentially prediction prognostic biomarker for colon adenocarcinoma.

Xi J, Zhang H, Li Y, Su H, Chen X, Liang X. Xi J, et al. Medicine (Baltimore). 2022 Sep 30;101(39):e30681. doi: 10.1097/MD.0000000000030681. Medicine (Baltimore). 2022. PMID: 36181111 Free PMC article.

5

Genistein exerts anti-colorectal cancer actions: clinical reports, computational and validated findings.

Liu X, Lan Y, Zhang L, Ye X, Shen Q, Mo G, Chen X. Liu X, et al. Aging (Albany NY). 2023 May 7;15(9):3678-3689. doi: 10.18632/aging.204702. Epub 2023 May 7. Aging (Albany NY). 2023. PMID: 37155147 Free PMC article.

6

Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysis.

Li Y, Liang X, Yang T, Guo S, Chen X. Li Y, et al. Front Oncol. 2022 Sep 26;12:878054. doi: 10.3389/fonc.2022.878054. eCollection 2022. Front Oncol. 2022. PMID: 36226060 Free PMC article.

7

Comparative efficacy and safety of immune checkpoint inhibitors for unresectable advanced melanoma: A systematic review and network meta-analysis.

Li Y, Liang X, Li H, Chen X. Li Y, et al. Int Immunopharmacol. 2023 Feb;115:109657. doi: 10.1016/j.intimp.2022.109657. Epub 2023 Jan 4. Int Immunopharmacol. 2023. PMID: 36608446 Review.

8

Nutritional intervention for the prognosis of nasopharyngeal carcinoma chemoradiotherapy patients: A meta-analysis.

He Y, Chen X, Yang T, Li Y, Tan S, Liu X. He Y, et al. Medicine (Baltimore). 2023 Oct 13;102(41):e35386. doi: 10.1097/MD.0000000000035386. Medicine (Baltimore). 2023. PMID: 37832079 Free PMC article.

9

Clinical efficacy and safety of Huachansu injection combination with platinum-based chemotherapy for advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials.

Tan X, Liang X, Xi J, Guo S, Meng M, Chen X, Li Y. Tan X, et al. Medicine (Baltimore). 2021 Sep 10;100(36):e27161. doi: 10.1097/MD.0000000000027161. Medicine (Baltimore). 2021. PMID: 34516509 Free PMC article.

10

Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.

Guo S, Li Y, Su H, Meng M, Xi J, Mo G, Chen X. Guo S, et al. Pharm Biol. 2021 Dec;59(1):1260-1275. doi: 10.1080/13880209.2021.1973038. Pharm Biol. 2021. PMID: 34541998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,980 results

Search Page

Filters